News & Press: Latest News

MDMA Statement on President-elect Trump's Nomination for HHS Secretary

Tuesday, November 29, 2016  
Share |

MDMA Statement on President-elect Trump's Nomination for HHS Secretary


WASHINGTON, DC -- Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA), issued the following statement today regarding President-elect Donald Trump's nomination of Congressman Tom Price for Secretary of Health and Human Services (HHS):

 

“Dr. Price has a rich history of improving patient care and fostering medical innovation, both which are central to the mission of HHS.  As a surgeon and as a Congressman, he has been a passionate voice on expanding patient access to treatments that address their specific needs.  If approved by the Senate, MDMA looks forward to working with Dr. Price to ensure that America's patients get timely access to the cures and therapies provided by medical technologies.

 

“Med tech innovators continue to deliver on the promise of a better tomorrow, and we will also work with Dr. Price to bridge the gap between the regulatory pathways and securing fair reimbursement.  As we all confront the ongoing challenges facing the health care delivery system, it is critical that we have an ecosystem in place where medical technology can provide the solutions we need.”

 

###